We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:

Search Results

Showing 1-20 of 531 results
  1. Irbesartan overcomes gemcitabine resistance in pancreatic cancer by suppressing stemness and iron metabolism via inhibition of the Hippo/YAP1/c-Jun axis

    Background

    Chemoresistance is the main reason for the poor prognosis of pancreatic ductal adenocarcinoma (PDAC). Thus, there is an urgent need to...

    Tianxing Zhou, Yongjie **e, ... **g Liu in Journal of Experimental & Clinical Cancer Research
    Article Open access 04 May 2023
  2. A collaborative study of the impact of N-nitrosamines presence and ARB recall on ARB utilization – results from IQVIA™ Disease Analyzer Germany

    Purpose

    Regulators are increasingly concerned with  the impact of recalls on drug adherence. In 2018, N-nitrosamines impurities were detected in...

    Karin Hedenmalm, Chantal Quinten, ... Efe Eworuke in European Journal of Clinical Pharmacology
    Article Open access 24 April 2023
  3. Understanding the Oral Absorption of Irbesartan Using Biorelevant Dissolution Testing and PBPK Modeling

    Poorly soluble weak bases form a significant proportion of the drugs available in the market thereby making it imperative to understand their...

    Navpreet Kaur, Poonam Singh Thakur, ... Arvind Kumar Bansal in AAPS PharmSciTech
    Article 09 March 2020
  4. Pleiotropic effects of AT-1 receptor antagonists in hypoxia induced by cardiac ischaemia

    The renin–angiotensin system (RAS) plays a crucial role and coordinates multiple body functions through its hormonal mechanism. The RAS is supported...

    Antonio Vitiello, Raffaele La Porta, ... Francesco Ferrara in Inflammopharmacology
    Article 15 March 2022
  5. Evaluation of Piperine as Natural Coformer for Eutectics Preparation of Drugs Used in the Treatment of Cardiovascular Diseases

    Piperine (PIP) was evaluated as a natural coformer in the preparation of multicomponent organic materials for enhancing solubility and dissolution...

    Krissia Wilhelm-Romero, María Isabel Quirós-Fallas, ... Andrea Mariela Araya-Sibaja in AAPS PharmSciTech
    Article 26 April 2022
  6. Highly Soluble Glimepiride and Irbesartan Co-amorphous Formulation with Potential Application in Combination Therapy

    One-third of the population of the USA suffers from metabolic syndrome (MetS). Treatment of patients with MetS regularly includes drugs prescribed...

    Jorge Cruz-Angeles, Marcelo Videa, Luz María Martínez in AAPS PharmSciTech
    Article 18 March 2019
  7. Discovery of SARS-CoV-2 Antiviral Drugs Through Large-Scale Virtual Screening of FDA-Approved Drugs

    Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the etiological agent responsible for the viral pneumonia outbreak of coronavirus...
    Wahiba Ezzemani, Ahd Ouladlahsen, ... Sayeh Ezzikouri in Advances in Antiviral Research
    Chapter 2024
  8. Irbesartan suppresses cardiac toxicity induced by doxorubicin via regulating the p38-MAPK/NF-κB and TGF-β1 pathways

    Doxorubicin (DOX) so far continues to be one of the most potent and effective anticancer drugs. Therefore, it is still needed to search for a safe...

    Nermin T. El-Said, Eman A. Mohamed, Ragia A. Taha in Naunyn-Schmiedeberg's Archives of Pharmacology
    Article 07 February 2019
  9. Erythropoietin in the Treatment of Anaemia

    Anaemia is a prevalent clinical presentation in individuals suffering from chronic kidney disease (CKD). This issue is linked to an elevated...
    Nibir Ghosh, Gourab Dey, ... Sourav De in Concepts in Pharmaceutical Biotechnology and Drug Development
    Chapter 2024
  10. Drug-Excipient Compatibility Study Through a Novel Vial-in-Vial Experimental Setup: A Benchmark Study

    Drug-excipient compatibility study (DECS) is one of the critical steps during pre-formulation studies to select the appropriate excipient to obtain a...

    Sonali Jain, Ravi P. Shah in AAPS PharmSciTech
    Article 10 May 2023
  11. Renin Angiotensin System Activity in Different Cancers: Mechanistic Insight and Preclinical Studies

    The Renin Angiotensin System (RAS) is maintain arterial blood pressure as well as fluid and electrolyte balance in human body. In recent there...
    Chapter 2023
  12. Renin-Angiotensin System: A Potential Therapeutic Target for Colorectal Cancer

    The Renin-Angiotensin System (RAS) is associated with regulation of blood pressure, electrolyte balance, and hemostasis. It is implicated in cancer...
    Lokesh Kumar Bhatt, Niraj Parihar, Kedar S. Prabhavalkar in The Renin Angiotensin System in Cancer, Lung, Liver and Infectious Diseases
    Chapter 2023
  13. The Renin-Angiotensin System and Cancer

    The renin-angiotensin system (RAS), classically known for its role in cardiovascular homeostasis, is increasingly recognized to be dysregulated in...
    Sabrina P. Koh, Ethan J. Kilmister, ... Swee T. Tan in The Renin Angiotensin System in Cancer, Lung, Liver and Infectious Diseases
    Chapter 2023
  14. Repaglinide-irbesartan drug interaction: effects of SLCO1B1 polymorphism on repaglinide pharmacokinetics and pharmacodynamics in Chinese population

    Purpose

    On account of the potential inhibition of OATP1B1 ( organic anion transporting polypeptide ) by angiotensin II receptor blockers (ARBs) and the...

    Qi Pei, Jun-Yan Liu, ... Zhao-Qian Liu in European Journal of Clinical Pharmacology
    Article 11 May 2018
  15. Stereolithography (SLA) in Pharmaceuticals

    Commercial stereolithography (SLA) 3D printing has been around for over three decades. However, only recently the technology has been employed in...
    Prashanth Ravi, Parimal Patel in Additive Manufacturing in Pharmaceuticals
    Chapter 2023
  16. Renin-Angiotensin System in Hematological Malignancies

    The regular functioning of the human body is the result of interactions between numerous organs and biological systems, with the Renin-Angiotensin...
    Nidhi Gupta, Shraddha Kapoor, ... Alpana Sharma in The Renin Angiotensin System in Cancer, Lung, Liver and Infectious Diseases
    Chapter 2023
  17. Prognosis of Midkine and AT1R expression in resectable head and neck squamous cell carcinoma

    Background

    Research studies have demonstrated that Midkine (MDK) can influence the expression and activity of Renin-angiotensin system (RAS)...

    Tai-Jan Chiu, Chang-Han Chen, ... Sheng‑Dean Luo in Cancer Cell International
    Article Open access 24 September 2023
  18. Impact of prior antihypertensive treatment on COVID-19 outcomes, by active ingredient

    Objectives

    To assess the impact of prior chronic treatment with angiotensin-converting enzyme inhibitors (ACEIs)/ angiotensin-receptor blockers...

    Rosa María García-Álvarez, Maruxa Zapata-Cachafeiro, ... Margarita Taracido-Trunk in Inflammopharmacology
    Article Open access 15 April 2024
  19. Incidence, characteristics, and risk factors of drug-associated muscle adverse reaction: a retrospective real-world study of inpatients

    Objective

    To analyze the clinical characteristics, incidence, and distribution of drug-associated muscle adverse reactions (DAMAR) in real-world...

    Anqi Zhao, Daihong Guo, ... An Fu in European Journal of Clinical Pharmacology
    Article 05 March 2024
  20. Relationship between antihypertensive drug use and number of people with high blood pressure in FY 2018: a descriptive epidemiological study based on the National Database of Health Insurance Claims and Specific Health Checkups of Japan open data

    Background

    In most countries barring Japan, antihypertensive drug use has been reported using the defined daily doses/1000 inhabitants/day (DID)....

    Kanako Mizuno, Ryo Inose, ... Yuichi Muraki in Journal of Pharmaceutical Health Care and Sciences
    Article Open access 09 December 2023
Did you find what you were looking for? Share feedback.